Literature DB >> 17172600

How to develop a business case for quality.

Kristin L Reiter1, Kerry E Kilpatrick, Sandra B Greene, Kathleen N Lohr, Sheila Leatherman.   

Abstract

OBJECTIVE: To describe the steps in developing a business case for quality-enhancing interventions (QEIs) in health care. ANALYSIS: The development of a business case for QEIs in health care involves 11 steps. These steps include (1) describing the intervention, (2) determining perspective, (3) identifying the effects of the intervention on quality, (4) designing the study, (5) identifying and measuring cash flows, (6) considering the effects of capacity constraints, (7) selecting a measure of return on investment, (8) determining the time horizon for the analysis, (9) determining the discount rate, (10) adjusting costs and savings for inflation, and (11) determining organizational readiness for business case development. A checklist offers guidance on assessing readiness for the business case.
CONCLUSION: The absence of a 'business case' for quality is frequently cited as the reason health care organizations do not implement QEIs, despite decades of careful research demonstrating their effectiveness. Our continuing commitment to advancing the discipline of business case analysis is based on a belief that delineating the cost and economic implications of investments in QEIs is a critical threshold issue to widespread adoption of evidence-based quality improvements. We believe it is appropriate and timely to consider how best to standardize approaches and move the field of business case analysis forward.

Mesh:

Year:  2006        PMID: 17172600     DOI: 10.1093/intqhc/mzl067

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  8 in total

Review 1.  Economic evaluation of pay-for-performance in health care: a systematic review.

Authors:  Martin Emmert; Frank Eijkenaar; Heike Kemter; Adelheid Susanne Esslinger; Oliver Schöffski
Journal:  Eur J Health Econ       Date:  2011-06-10

2.  Performing well on nursing home report cards: does it pay off?

Authors:  Jeongyoung Park; R Tamara Konetzka; Rachel M Werner
Journal:  Health Serv Res       Date:  2010-10-28       Impact factor: 3.402

3.  Challenges and facilitators of community clinical oncology program participation: a qualitative study.

Authors:  Ann Scheck McAlearney; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Paula H Song
Journal:  J Healthc Manag       Date:  2013 Jan-Feb

4.  The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.

Authors:  Paula H Song; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Ann Scheck McAlearney
Journal:  Health Care Manage Rev       Date:  2013 Oct-Dec

5.  Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.

Authors:  Ann Scheck McAlearney; Paula H Song; Kristin L Reiter
Journal:  Contemp Clin Trials       Date:  2012-08-19       Impact factor: 2.226

6.  The effect of adrenaline and of alpha- and beta-adrenergic blocking agents on ATP concentration and on incorporation of 32Pi into ATP in rat fat cells.

Authors:  J M Stein
Journal:  Biochem Pharmacol       Date:  1975-09-15       Impact factor: 5.858

7.  An iron triangle ROI model for health care.

Authors:  David N van der Goes; Nicholas Edwardson; Veeshan Rayamajhee; Christine Hollis; Dawn Hunter
Journal:  Clinicoecon Outcomes Res       Date:  2019-05-10

8.  The role of organizational research in implementing evidence-based practice: QUERI Series.

Authors:  Elizabeth M Yano
Journal:  Implement Sci       Date:  2008-05-29       Impact factor: 7.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.